Abata Therapeutics has raised $95M in total funding. Latest round: Seed. Backed by Third Rock Ventures.
Abata Therapeutics funding overview
Abata Therapeutics has raised $95M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Seed announced in June 2021. The round record for Abata Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Third Rock Ventures.
Abata Therapeutics at a glance
Total raised
$95M
Latest round
Seed
Latest round date
June 2021
Notable investors
Third Rock Ventures
Frequently asked about Abata Therapeutics funding
How much has Abata Therapeutics raised?
Abata Therapeutics has raised $95M in total disclosed funding across the rounds on record.
Who has invested in Abata Therapeutics?
Third Rock Ventures are named among the investors backing Abata Therapeutics.
What was the latest Abata Therapeutics funding round?
The most recent disclosed round is a Seed, announced in June 2021.
Where is Abata Therapeutics based?
No headquarters location is disclosed for Abata Therapeutics.
When did Abata Therapeutics last raise?
The last disclosed Abata Therapeutics round closed in June 2021 at Seed.
We update the Abata Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies and their backers are listed below.
